Skip to content

It looks like we may have content for your preferred language. Would you like to view this page in English?

Fed. Circ. Affirms PTAB Ax Of Cialis, Adcirca Patents

Loeb & Loeb attorneys Mark Waddell, Kathleen Gersh, Warren MacRae and Alexandra Cavazos are featured as counsel to Actelion in multiple inter partes reviews regarding Cialis and Adcirca patents. This article discusses the Federal Circuit’s affirmation of two Patent Trial and Appeal Board IPR review decisions that asserted claims of patents covering the erectile dysfunction drug Cialis and pulmonary arterial hypertension drug Adcirca are invalid as obvious.

Click here to read the article on Law360’s website.